Dr. Gandy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St # 1139
7th Floor
New York, NY 10029Phone+1 212-241-7076Fax+1 212-860-4952
Summary
- Dr. Sam Gandy is a neurologist in New York, NY, affiliated with Mount Sinai and the James J. Peters Veterans Affairs Medical Center. He received his MD and PhD degrees from Medical University of South Carolina and has been in practice 42 years. He has published over 300 original research papers and reviews. He has been continuously funded by the NIH since 1986. His h index is 95.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1983 - 1986
- New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1982 - 1983
- Medical University of South CarolinaClass of 1982
- Charleston Southern UniversityB.S., Summa Cum Laude, 1976
Certifications & Licensure
- FL State Medical License 2020 - Present
- NY State Medical License 1983 - 2026
- GA State Medical License 2007 - 2008
- PA State Medical License 2002 - 2008
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Visiting Principal Research Fellow South Australia Health and Medical Research Institute, 2014
- Arthur Cherkin Memorial Award in Geriatric Medicine University of California, Los Angeles, 2008
- Alpha Omega Alpha 1981
Clinical Trials
- Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD) Start of enrollment: 2018 Jul 03
Publications & Presentations
PubMed
- 9 citationsPlasma high-density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume.Steve Pedrini, James D Doecke, Eugene Hone, Penghao Wang, Rohith Thota
Journal of Neurochemistry. 2022-10-01 - 131 citationsCalorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus)Weiping Qin, Mark E. Chachich, Mark A. Lane, George S. Roth, Mark Bryant
Journal of Alzheimer's Disease. 2006-01-01 - 93 citationsTransformative Network Modeling of Multi-omics Data Reveals Detailed Circuits, Key Regulators, and Potential Therapeutics for Alzheimer’s DiseaseMinghui Wang, Aiqun Li, Michiko Sekiya, Noam D. Beckmann, Xiuming Quan
Neuron. 2021-01-20
Journal Articles
- Serum high-density lipoprotein is associated with better cognitive function in a cross-sectional study of aging womenBates KA, Sohrabi HR, Rainey-Smith SR, Weinborn M, Bucks RS, Rodrigues M, Beilby J, Howard M, Taddei K, Martins G, Paton A, Shah T, Dhaliwal SS, Foster JK, Martins IJ,..., Int J Neurosci, 1/1/2017
- Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCA...Ruiz HH, Chi T, Shin AC, Lindtner C, Hsieh W, Ehrlich M, Gandy S, Buettner C, Alzheimers Dement, 1/1/2016
- Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer'srelated Sorcs1Knight EM, Ruiz HH, Kim SH, Harte JC, Hsieh W, Glabe C, Klein WL, Attie AD, Buettner C, Ehrlich ME, Gandy S, Acta Neuropathol Commun, 1/1/2016
- Join now to see all
Books/Book Chapters
Press Mentions
- Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of DiseaseMay 4th, 2023
- Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Disease ProgressMay 3rd, 2023
- A Neurologist Answers Questions Patients Might Have About the New Alzheimer’s Drug LecanemabJanuary 27th, 2023
- Join now to see all
Grant Support
- Alzheimer Mouse Model For Intraneuronal Amyloid-Beta Oligomer BiologyVeterans Affairs2011–2012
- Evidence For Gamma-Secretase Dysfunction In Sporadic ADNational Institute On Aging2010–2012
- Phase 11-Grape Seed Extract As Anti-Oligomerization Agent In Alzheimer'S DiseaseNational Center For Complementary &Alternative Medicine2010
- Lipoproteins, Signal Transduction, And Activation Of APP Ectodomain SheddingNational Institute On Aging2007–2009
- Interdisciplinary Approach To Alzheimer Drug DiscoveryNational Institute On Aging2007–2009
- Presenilin Domains And Reconstitution Of CatalysisNational Institute On Aging2007
- Presenilin Domains And Reconstitution Of CatalysisNational Institute On Aging2005–2006
- Lipoproteins, Signal Transduction, Activation Of APP ECTNational Institute On Aging2005–2006
- Interdisciplinary Approach To Alzheimer Drug DiscoveryNational Institute On Aging2002–2006
- Administrative CoreNational Institute On Aging2005
- Estrogen Modulation Of Brain Abeta Metabolism In VivoNational Institute Of Neurological Disorders And Stroke2002–2004
- Transmitter Neuroanatomy In Alzheimers DiseaseNational Institute On Aging2002
- Babaa Receptors In Aging &Alzheimer'S DiseaseNational Institute On Aging2002
- Estrogen Modulation Of Brain Abeta Metabolism In VivoNational Institute Of Neurological Disorders And Stroke2001–2002
- Protein Protein Interactions In Amyloid Beta MetabolismNational Institute On Aging2000–2002
- Interdisciplinary Approach To Alzheimer Drug DiscoveryNational Institute On Aging2000–2001
- Cell Biological Studies Of Amyloid Precursor ProteinNational Institute On Aging1996–2000
- Generation &Regulation Of Amyloid Peptide Variants By Neurons: AlzheimerNational Center For Research Resources1999
- Estrogen Reduces Neuronal Generation Of Alzheimer Amyloid Peptides LENational Center For Research Resources1999
- Regulated Cleavage Of Amyloid Precursor--Molecular BasisNational Institute On Aging1996–1997
- Molecular Cell Biology Of Alzheimer AmyloidogenesisNational Institute On Aging1995
- Signal Transduction &Alzheimer'S Disease--Cell Biological StudiesNational Institute On Aging1991–1995
- Molecular Cell Biology Of Alzheimer AmyloidogenesisNational Institute On Aging1992–1994
- Cell Biology Of Amyloid Precursor Protein Processing In Vitro, In VivoNational Institute On Aging1991–1994
- Regulation Of Amyloid Formation In Alzheimers DiseaseNational Center For Research Resources1991
- Characterization Of A Neuron-Specific PhosphoproteinNational Institute Of Neurological Disorders And Stroke1986–1990
Professional Memberships
- Member
Other Languages
- Spanish, Korean, Japanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: